Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
968.2 INR | -3.72% | +1.54% | +40.48% |
05-09 | Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel | MT |
05-09 | Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5% | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.48% | 12.12B | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
-9.64% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B | |
+9.14% | 4.83B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Zydus Lifesciences' Consolidated Net Profit Increases in Fiscal Q3; Shares Jump 7%